Maternal endothelin-1 and cyclic guanosine monophosphate concentrations in pregnancies complicated by pregravid and gestational diabetes mellitus

Gynecologic and Obstetric Investigation

Volumn 69, Issue 1, 2010, Pages 46-50

  Świderski, Sławomir ^a   Celewicz, Zbigniew ^a   Miazgowski, Tomasz ^a   Ogonowski, Jarosław ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cyclic guanosine monophosphate; Gestational diabetes; Maternal endothelin 1; Pregravid diabetes

Indexed keywords

CYCLIC GMP; ENDOTHELIN 1; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MULTIPARA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PRIMIPARA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

BLOOD GLUCOSE; CYCLIC GMP; DIABETES, GESTATIONAL; ENDOTHELIN-1; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PREGNANCY; PREGNANCY IN DIABETICS; STATISTICS, NONPARAMETRIC;

EID: 70350540585     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253851     Document Type: Article

References (29)

1. Pedersen J, Molsted-Pedersen L: Prognosis of the outcome of pregnancies in diabetics. A new classification. Acta Endocrinol 1965; 50: 70-78.
2. Cundy T, Slee F, Gamble G, Neale L: Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes. Diabet Med 2002; 19: 482-489. (Pubitemid 34639159)
3. Vambergue A, Nuttens MC, Goeusse P, Biausque S, Lepeut M, Fontaine P: Pregnancy- induced hypertension in women with gestational carbohydrate intolerance: the Diagest study. Eur J Obstet Gynecol Reprod Biol 2002; 102: 31-35.
4. Bryson CL, Ioannou GN, Rulyak SJ, Critchlow C: Association between gestational diabetes and pregnancy-induced hypertension. Am J Epidemiol 2003; 158: 1148-1153.
5. Sibai BM, Caritis S, Hauth J, Lindheimer M, VanDorsten JP, MacPherson C, Klebanoff M, Landon M, Miodovnik M, Paul R, Meis P, Dombrowski M, Thurnau G, Roberts J, Mc- Nellis D: Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000; 182: 364-369.
6. Rust OA, Bofill JA, Zappe DH, Hall JE, Burnett JC, Martin JN: The origin of endothelin-1 in patients with severe preeclampsia. Obstet Gynecol 1997; 89: 754-757.
7. Slowinski T, Neumayer HH, Stolze T, Gossing G, Halle H, Hocher B: Endothelin system in normal and hypertensive pregnancy. Clin Sci (Lond) 2002; 103(suppl 48):446S-449S.
8. Shaarawy M, Abdel-Magid A: Plasma endothelin-1 and mean arterial pressure in the prediction of pre-eclampsia. Int J Obstet Gynecol 2000; 68: 105-111.
9. El-Mesallamy H, Suwailem S, Hamdy N: Evaluation of C-reactive protein, endothelin- 1, adhesion molecule(s), and lipids as inflammatory markers in type 2 diabetes mellitus patients. Mediators Inflamm 2007; 2007: 73635.
10. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O: Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995; 85: 353-356.
11. Solomon CG, Graves SW, Greene MF, Graves SW, Seely EW: Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension 1994; 23: 717-721.
12. Innes KE, Wimsatt JH, McDuffie R: Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol 2001; 97: 905-910.
13. Wolf M, Sandler L, Munoz K, Hsu K, Ecker JL, Thadhani R: First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002; 87: 1563-1568.
14. Lyall F, Young A, Greer IA: Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995; 173: 714-718.
15. Shaamash AH, Elsnosy E, Makhlouf A, Zakhara MM, Ibrahim OA, El-Dien HM: Maternal and fetal serum nitric oxide concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynecol Obstet 2000; 68: 207-214.
16. WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. WHO/NCD/NCS/99.2. Geneva, WHO, 1999.
17. Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR, Gunderson EP, Herman WH, Hoffman LD, Inturrisi M, Jovanovic LB, Kjos SI, Knopp RH, Montoro MN, Ogata ES, Paramsothy P, Reader DM, Rosenn BM, Thomas AM, Kirkman MS: Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 2008; 31: 1060-1079.
18. Wolff K, Carlstrom K, Fyhrquist F, Hemsen A, Lunell NO, Nisell H: Plasma endothelin in normal and diabetic pregnancy. Diabetes Care 1997; 20: 653-656.
19. Lygnos MC, Pappa KI, Papadaki HA, Relakis C, Koumantakis E, Anagnou NP, Eliopoulos GD: Changes in maternal plasma levels of VEGF, bFGF, TGF- β1 , ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo 2006; 20: 157-163.
20. Best RM, Hayes R, Hadden DR, Chakravarthy U, Archer DB: Plasma levels of endothelin-1 in diabetic retinopathy in pregnancy. Eye 1999; 13: 179-182.
21. Celewicz Z: Vasoactive factors and plasma fibronectin in pregnancy complicated by diabetes mellitus, chronic hypertension and preeclampsia. Ann Acad Med Stetin 2000; 63(suppl):1-116.
22. Lteif A, Vaishnava P, Baron AD, Mather KJ: Endothelin limits insulin action in obese/insulin- resistant humans. Diabetes 2007; 56: 728-734.
23. Ferri C, Bellini C, Desideri G, De Mattia G, Santucci A: Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care 1996; 19: 504-506.
24. Wolpert HA, Steen SN, Istfan NW, Simonson DC: Insulin modulates circulating endothelin-1 levels in humans. Metabolism 1993; 42: 1027-1030.
25. Stefan N, Stumvoll M, Weyer C, Bogardus C, Tataranni PA, Pratley RE: Exaggerated insulin secretion in Pima Indians and African- Americans but higher insulin resistance in Pima Indians compared to African-Americans and Caucasians. Diabet Med 2004; 21: 1090-1095.
26. Diejomaoh FM, Omu AE, Al-Busiri N, Taher S, Al-Othman S, Fatinikun T, Fernandes S: Nitric oxide production is not altered in preeclampsia. Arch Gynecol Obstet 2004; 269: 237-243.
27. Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS: Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 2002; 25: 1055-1059.
28. Piatti PM, Monti LD, Galli L, Fragasso G, Valsecchi G, Conti M, Gernone F, Pontiroli AE: Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome. Metabolism 2000; 49: 748-752.
29. Nielsen LR, Ekbom P, Damm P, Glumer C, Frandsen MM, Jensen DM, Mathiesen ER: HbA 1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004; 27: 1200-1201.